Big Pharma's Key Lifecycle Management Strategies - Maximizing the Market Potential
Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs
Drug Discovery in India and China - Gaining Momentum with Increasing Pressure on Cost Cutting
Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma
Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis
The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways
The Future of Contract Manufacturing - Market Forecasts To 2015 and Geographical Trends